我国植入式脑机接口启动临床入组 数百万脊髓损伤患者迎来曙光

Core Insights - The 20th Asian Neuro-Oncology Annual Meeting revealed the initiation of patient enrollment for a clinical cohort study on brain-machine interfaces led by Huashan Hospital and Beijing Xuanwu Hospital, aimed at validating the effectiveness and safety of implanted brain-machine interface treatment solutions [1] Group 1: Clinical Research - The clinical cohort study on brain-machine interfaces is focused on key issues such as effectiveness and safety [1] - The study is part of a broader initiative to advance brain-machine interface technology in clinical settings, with 2025 identified as a critical year for the technology's clinical application in China [1] Group 2: Industry Development - A new professional subcommittee for brain-machine interfaces and neural regulation will be established in Shanghai, bringing together various sectors including academia, clinical practice, and industry to foster innovation [1] - Prior to this, cities like Beijing and Shanghai have already implemented industry plans related to brain-machine interfaces, with a goal to complete clinical trials for more than five invasive products by 2030 [1]